Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher prices for some of the company's products will follow. Trump is set to ...

Robust demand across its pharmaceutical and specialty solutions segment was the impetus behind Cardinal Health raising its fiscal 2025 enterprise guidance, said Jason Hollar, CEO of Cardinal ...

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Hold rating on Cardinal Health (CAH – Research Report), with a price target of $135.00. The company’s shares closed ...

Jan 30 (Reuters) - Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its ...

Pre-Market: 5:06:54 a.m. EST ...

View Cardinal Health, Inc. (CAH) current and estimated P/E ratio data provided by Seeking Alpha.